These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31231884)

  • 1. Left ventricular sensing in cardiac resynchronization devices-opportunities and pitfalls for device programming.
    Haeberlin A; Ploux S; Noel A; Chauvel R; Welte N; Marchand H; Haissaguerre M; Ritter P; Bordachar P
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1352-1361. PubMed ID: 31231884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of impaired biventricular pacing in cardiac resynchronization devices with left ventricular sensing.
    Haeberlin A; Ploux S; Noel A; Chauvel R; Welte N; Marchand H; Haïssaguerre M; Ritter P; Eschalier R; Bordachar P
    Pacing Clin Electrophysiol; 2020 Mar; 43(3):332-340. PubMed ID: 32039491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring device settings in cardiac resynchronization therapy using electrograms from pacing electrodes.
    Engels EB; Mafi-Rad M; Hermans BJM; Aranda A; van Stipdonk AMW; Rienstra M; Scheerder COS; Maass AH; Prinzen FW; Vernooy K
    Europace; 2018 Jul; 20(7):1146-1153. PubMed ID: 29106563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular wall motion analysis to guide management of CRT non-responders.
    Nitsche B; Eitel C; Bode K; Wetzel U; Richter S; Döring M; Hindricks G; Piorkowski C; Gaspar T
    Europace; 2015 May; 17(5):778-86. PubMed ID: 25825461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of the Q (q) wave in lead I and QRS frontal axis for diagnosing loss of left ventricular capture during cardiac resynchronization therapy.
    Cao YY; Su YG; Bai J; Wang W; Wang JF; Qin SM; Ge JB
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):64-9. PubMed ID: 25112169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
    Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative performance of the Quartet® left ventricular heart lead.
    Tomassoni G; Baker J; Corbisiero R; Love C; Martin D; Niazi I; Sheppard R; Worley S; Beau S; Greer GS; Aryana A; Cao M; Harbert N; Zhang S;
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):449-56. PubMed ID: 23339555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy (CRT) with right ventricular sense triggered left ventricular pacing benefits for the hemodynamics compared with standard CRT for chronic congestive heart failure: A cross-over study.
    Pu LJ; Wang Y; Zhao L; Luo ZL; Hua BT; Han MH; Li SM; Yang J; Li L; Peng YZ; Guo T
    Cardiol J; 2015; 22(1):80-6. PubMed ID: 25179313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the 12-lead electrocardiogram in the follow-up of patients with cardiac resynchronization devices. Part I.
    Barold SS; Herweg B
    Cardiol J; 2011; 18(5):476-86. PubMed ID: 21947982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the timing cycles of a cardiac resynchronization device designed with left ventricular sensing.
    Barold SS; Kucher A
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1324-37. PubMed ID: 25212575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal pacing for right ventricular and biventricular devices: minimizing, maximizing, and right ventricular/left ventricular site considerations.
    Gillis AM
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):968-77. PubMed ID: 25336367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch block.
    Engels EB; Végh EM; Van Deursen CJ; Vernooy K; Singh JP; Prinzen FW
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):176-83. PubMed ID: 25230363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy when no lateral pacing option exists: vectorcardiographic guided non-lateral left ventricular lead placement predicts acute hemodynamic response.
    Ross S; Odland HH; Aranda A; Edvardsen T; Gammelsrud LO; Haland TF; Cornelussen R; Hopp E; Kongsgaard E
    Europace; 2018 Aug; 20(8):1294-1302. PubMed ID: 29036446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of left ventricular lead position relative to scar location on response to cardiac resynchronization therapy: a model study.
    Huntjens PR; Walmsley J; Ploux S; Bordachar P; Prinzen FW; Delhaas T; Lumens J
    Europace; 2014 Nov; 16 Suppl 4():iv62-iv68. PubMed ID: 25362172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of a novel active fixation quadripolar left ventricular lead for cardiac resynchronization therapy: Attain Stability Quad Clinical Study results.
    Jackson KP; Faerestrand S; Philippon F; Yee R; Kong MH; Kloppe A; Bongiorni MG; Lee SF; Canby RC; Pouliot E; van Ginneken MME; Crossley GH
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1147-1154. PubMed ID: 32162757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of cardiac resynchronization therapy by atrial premature complexes.
    Barold SS; Kucher A
    J Electrocardiol; 2018; 51(2):247-251. PubMed ID: 29162282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multipoint left ventricular pacing in a single coronary sinus branch improves mid-term echocardiographic and clinical response to cardiac resynchronization therapy.
    Pappone C; Ćalović Ž; Vicedomini G; Cuko A; McSpadden LC; Ryu K; Romano E; Baldi M; Saviano M; Pappone A; Ciaccio C; Giannelli L; Ionescu B; Petretta A; Vitale R; Fundaliotis A; Tavazzi L; Santinelli V
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):58-63. PubMed ID: 25109276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: A feature-tracking and contrast-enhanced cardiovascular magnetic resonance study.
    Taylor RJ; Umar F; Panting JR; Stegemann B; Leyva F
    Heart Rhythm; 2016 Feb; 13(2):481-9. PubMed ID: 26498258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable?
    Biffi M; Bertini M; Ziacchi M; Diemberger I; Martignani C; Boriani G
    Europace; 2014 Apr; 16(4):533-40. PubMed ID: 24072448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.